Significant effort has been devoted to discovering microRNA (miRNA) disease biomarkers.
In particular, miRNAs in whole blood or specific blood components are candidates for …

MicroRNAs (miRNAs) are secreted by cells in vesicles, bound in a ribonucleoprotein
complex or as free molecules. These miRNA secretion pathways are dysregulated in cancer …

BACKGROUND MicroRNAs (miRNAs) are non‐coding small RNAs, involved in post‐
transcriptional regulation of many target genes. METHODS Five miRNAs that have been …

Predicting the risk of metastasis before starting prostate cancer (PCa) treatment can
minimize the overtreatment of indolent cases and help choosing appropriate treatment. The …

In many cancer types, the expression and function of∼ 22 nucleotide-long microRNAs
(miRNA) is deregulated. Mature miRNAs can be stably detected in extracellular vesicles …

Inflammation is a part of the complex biological response of inflammatory cells to harmful
stimuli, such as pathogens, irritants, or damaged cells. This inflammation has been linked to …

Abstract microRNAs (miRNAs) are small non-coding RNAs that control gene expression
posttranscriptionally and are part of the giant non codifying genoma. Cumulating data …

Elevated levels of miR-21 expression are associated with many cancers, suggesting it may
be a promising clinical biomarker. In prostate cancer (PCa), however, there is still no …

Exosomes are small extracellular vesicles with a lipid bilayer structure secreted from
different cell types which can be found in various body fluids including blood, pleural fluid …

Prostate cancer (PCa) is the second most common diagnosed malignant disease in men
worldwide. Although serum PSA test dramatically improved the early diagnosis of PCa, it …